This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: National Health Research Institutes, Development Center for Biotechnology. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2024-2026
Title: Pei-Shan Wu: Innovator in Neurotensin Receptor Research
Introduction
Pei-Shan Wu is a notable inventor based in Miaoli, Taiwan. She has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies targeting neurotensin receptor 1 (NTSR1). Her work has implications for treating various diseases related to NTSR1 activity.
Latest Patents
Pei-Shan Wu holds a patent for "Humanized anti-human neurotensin receptor 1 antibodies and their uses." This patent describes a humanized anti-neurotensin receptor 1 (NTSR1) antibody or an antigen-binding fragment thereof. It also outlines methods for treating, prophylactic treating, and preventing diseases and disorders caused by or related to NTSR1 activity and signaling. Additionally, the patent includes a method or kit for detecting NTSR1 in a sample. She has 1 patent to her name.
Career Highlights
Throughout her career, Pei-Shan Wu has worked with prominent organizations such as the Development Center for Biotechnology and the National Health Research Institutes. Her research has contributed to advancements in understanding and manipulating NTSR1 for therapeutic purposes.
Collaborations
Pei-Shan Wu has collaborated with notable colleagues, including Liang-Yu Hsia and Ren-Huang Wu. These partnerships have enhanced her research and expanded the impact of her work in the scientific community.
Conclusion
Pei-Shan Wu is a pioneering inventor whose work on neurotensin receptor 1 antibodies has the potential to transform therapeutic approaches for related diseases. Her contributions to biotechnology continue to inspire future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile